Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
Active & Responsive
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
Location: Tampa FL, Rockledge FL, Miami FL, Jacksonville FL,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06798012
Phase 2, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Tampa FL, Cross City FL, Boca Raton FL,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
BBD Longitudinal Study of Osteogenesis Imperfecta
for
Osteogenesis Imperfecta
Location: Tampa FL, Houston TX, Washington D.C. DC, Baltimore MD,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT02432625
Recruiting
Active & Responsive
Effects of Recursive Self-feedback on Speech Production in Aphasia
for
Aphasia, Stroke
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70+
Code: NCT06323629
Recruiting
Active & Responsive
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Tampa FL, Port Charlotte FL, New Port Richey FL,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase 2, Recruiting
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: Tampa FL, Gainesville FL, Miami FL, Nashville TN,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Tampa FL, Orlando FL, Boca Raton FL, Hallandale FL,
Sponsor: Appello Pharmaceuticals, Inc.
Sex: All
Age: 30 - 70+
Code: NCT07432958
Phase 2, Recruiting
Active & Responsive
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
for
Diabetic Retinopathy, Macular Edema
Location: Tampa FL, Wildwood FL, Gainesville FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07705555
Phase 3, Recruiting
Active & Responsive
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
for
Irritable Bowel Syndrome
Location: Tampa FL, Port Orange FL, Boca Raton FL, Miami FL,
Sponsor: Dynogen Pharmaceuticals
Sex: Female
Age: 18 - 65
Code: NCT00547469
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Tampa FL, Lakeland FL, Orlando FL, Ocoee FL, Atlanta GA,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07816367
Phase 3, Recruiting
Active & Responsive
Twiist Postmarket Surveillance Study for Type 1 Diabetes
for
Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus
Location: Tampa FL
Sponsor: Deka Research and Development
Sex: All
Age: 6+
Code: NCT07356089
Recruiting
Active & Responsive
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
for
Focal Onset Seizures
Location: Port Charlotte FL, Kissimmee FL, Port Saint Lucie FL,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT06798896
Phase 2, Recruiting
Active & Responsive
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
for
Type 2 Diabetes Mellitus
Location: Lakeland FL, Lake City FL, Ridgeland MS, Kingsport TN,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07662109
Phase 3, Recruiting
Active & Responsive
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.